The Interprofessional Medication Assessment for Older Patients
The Interprofessional Medication Assessment for Older Patients - a Multicenter Randomized Trial in Primary Care Setting
研究概览
详细说明
Aging increases the risk of adverse effects and interactions caused by medication. Medication reconciliation and medication review are well-known practices to optimize medicines use. Both interventions usually require a team-based approach to be effective. Medication reconciliation is the process of obtaining and documenting a complete and accurate list of current patient medications and comparing this list with medication orders at each point of care transition to identify and rectify any discrepancies before patient harm occurs. Medication review is the process of evaluating current medication treatment to manage the risk and optimize the outcomes of medication treatment by detecting, solving, and preventing medication-related problems. The present study focuses on medication assessment including both medication reconciliation and review combined to clinical assessment of an individual patient.
According to a systematic review there is a need for research focusing on medication management in community settings and especially to assess the impact of medication assessment on clinical outcomes.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
-
Forssa、芬兰、FI 30100
- Welfare district of Forssa
-
Haapajärvi、芬兰、FI 85800
- Selänne Basic Health Care District
-
Juva、芬兰、FI-51900
- Juva Health Care
-
Lahti、芬兰、FI-15100
- City of Lahti, home care
-
Savonlinna、芬兰、FI-57100
- Eastern Savo Hospital District
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
Home dwelling ≥65 years-old persons registered to public home care services and who
- have had dizziness, orthostatic hypotension or have fallen or
- use at least six medicines
Exclusion Criteria:
Home care is not responsible for patient's medication, for example due to severe chronic illness (for example severe renal insufficiency or cancer with active treatment in secondary or tertiary care).
学习计划
研究是如何设计的?
设计细节
- 主要用途:支持治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
---|---|
有源比较器:Active comparator
In addition to usual care, participants allocated to intervention group will receive medication assessment and treatment plan based on it
|
Intervention
|
无干预:Usual care
Usual care (reference group).
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
---|---|
Functional capacity IADL (Instrumental Activities of Daily Living)
大体时间:at 6 months from baseline
|
at 6 months from baseline
|
Functional capacity ADL (Activities of daily living;KATZ)
大体时间:at 6 months from baseline
|
at 6 months from baseline
|
Functional capacity TUG (Timed up and go)
大体时间:at 6 months from baseline
|
at 6 months from baseline
|
Functional capacity MMSE ( Mini-mental state examination)
大体时间:at 6 months from baseline
|
at 6 months from baseline
|
Functional capacity GDS (Geriatric Depression Scale)-15
大体时间:at 6 months from baseline
|
at 6 months from baseline
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Use of health care services
大体时间:at 6 and 12 months from baseline
|
visits to physician, hospital days and nursing care at home
|
at 6 and 12 months from baseline
|
Need of services delivered to home
大体时间:at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
|
Number of medicines
大体时间:at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
|
Quality of medicines
大体时间:at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
|
Cost of medicines
大体时间:at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
|
Health related quality of life assessed with EQ-5D
大体时间:at 6 and 12 months from baseline
|
at 6 and 12 months from baseline
|
合作者和调查者
调查人员
- 学习椅:Pekka Mäntyselkä, MD、professor
出版物和有用的链接
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- ILMA
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.